Publications

Research Publications

Lee, G., Graham, G.L. Noble, B.L, Trammell, T.S., McCarthy, D.M., Anderson, L.R., Rubinstein, M., Bhide, P.G., & Stanwood, G.D. Behavioral and neuroanatomical consequences of cell-type specific loss of dopamine D2 receptors in the mouse cerebral cortex, Front. Behav. Neurosci., Jan 13;15:815713. doi: 10.3389/fnbeh.2021.815713. PMID: 35095443.

Van Lith, T., Cheshure, A., Pickett, S.M., Stanwood, G.D., & Beerse, M. Mindfulness Based Art Therapy Protocol to Determine Efficacy in Reducing College Stress and Anxiety, BMC Psychol. 2021 Sep 3;9(1):134. doi: 10.1186/s40359-021-00634-2.

Graham, D.L., Madkour, H.S., Noble, B.L., Schatschneider, C. & Stanwood, G.D. Long-term functional alterations following prenatal GLP-1R activation Neurotoxicology and Teratology, 2021 Apr 20;87:106984. doi: 10.1016/j.ntt.2021.106984. PMID: 33864929.

Trammell T.S., Henderson N.L., Madkour H.S., Stanwood G.D., Graham D.L. GLP-1R activation alters performance in cognitive tasks in a sex-dependent manner. Neurol Sci. 2020 Nov 22. doi: 10.1007/s10072-020-04910-8. PMID: 33222103 .

Graham, D.L., Durai, H.H., Trammell, T.S., Mortlock, D.P., Galli, A. & Stanwood, G.D. A novel mouse model of glucagon-like peptide-1 receptor expression: a look at the brain, Journal of Comparative Neurology, 2020 Mar 14. doi: 10.1002/cne.24905. PMID: 32170734.

Beerse, M.E., Van Lith, T., & Stanwood, G.D. Therapeutic Psychological and Biological Responses to Mindfulness-Based Art Therapy, Stress and Health 2020 Feb 19. doi: 10.1002/smi.2937. PMID: 32073202.

Anacker, A.M.J., Moran, J.T., Santarelli, S., Forsberg, C.G., Rogers, T.D., Stanwood, G.D., Hall, B.J., Delpire, E., Veenstra-VanderWeele, J., & Saxe, M.D. Enhanced social dominance and altered neuronal excitability in the prefrontal cortex of male KCC2b mutant mice. Autism Res. 2019 Apr 12. doi: 10.1002/aur.2098. PMID: 30977597.

Beerse, M.E., Van Lith, T. & Stanwood, G.D. Is There a Biofeedback Response to Art Therapy? A Technology-Assisted Approach for Reducing Anxiety and Stress in College Students, Sage Open 2019, https://doi.org/10.1177/2158244019854646 .

Toki, S., Goleniewska, K., Reiss, S., Zhang, J., Bloodworth, M.H., Stier,M.T., Zhou, W., Newcomb, D.C., Ware, L.B., Stanwood, G.D., Galli, A., Boyd, K.L., Niswender, K.D., & Peebles Jr., R.S. Glucagon-like peptide 1 receptor agonist, liraglutide inhibits allergen-induced IL-33 release and reduced group 2 innate lymphoid cell (ILC2) cytokine production in vivo, J Allergy Clin Immunol. 2018 Jan 10. pii: S0091-6749(18)30027-7. PMID: 29331643.

Davis G.L., Stewart A., Stanwood G.D., Gowrishankar R., Hahn M.K., & Blakely R.D. Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice. Behav Brain Res. 2018 Jan 30;337:61-69. PMID: 28964912.

Zike, I.D., Chohan, M.O., Kopelman, J.M., Krasnow, E., Flicker, D., Nautiyal, K.M., Bubser, M.  Kellendonk, C., Jones, C.K., Stanwood, G.D., Tanaka, K., Moore, H., Ahmari, S., & Veenstra-VanderWeele, J. OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior, Proc Natl Acad Sci U S A. 2017 May 30;114(22):5719-5724. PMID: 28507136.

Muller, C.L., Anacker, A.M., Rogers, T.D., Goeden, N., Keller, E.H., Forsberg, C.G., Kerr, T.M., Wender, C., Anderson, G.M., Stanwood, G.D., Blakely, R.D., Bonnin, A., Veenstra-VanderWeele J. Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment, Neuropsychopharmacology. 2017 Jan;42(2):427-436. doi: 10.1038/npp.2016.166. Epub 2016 Aug 23. PMID: 27550733.

Reddy I.A., Pino J.A., Weikop P., Osses N., Sørensen G., Bering T., Valle C., Bluett R.J., Erreger K., Wortwein G., Reyes J.G., Graham D., Stanwood G.D., Hackett T.A., Patel S., Fink-Jensen A., Torres G.E. Galli A. Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Transl Psychiatry. 2016 May 17;6:e809. doi: 10.1038/tp.2016.86

Sørensen, G., Reddy, I., Weikop, P., Graham, D.L., Stanwood, G.D., Wortwein, G., Galli, A. & Fink-Jensen, A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice, Pharmacology, Biochemistry and Behavior, 2015, 149:262-268. doi: 10.1016/j.physbeh.2015.06.013.

Graham, D.L., Buendia, M.A., Durai, H.H, Akel, M.J., Chapman, M.A. & Stanwood, G.D. Cerebral cortical deletion of G?q (Gnaq) alters behavior, Synapse, May 12. doi: 10.1002/syn.21830. [Epub ahead of print].

Sørensen, G., Reddy, I., Weikop, P., Graham, D.L., Stanwood, G.D., Wortwein, G., Galli, A. & Fink-Jensen, A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice, Pharmacology, Biochemistry and Behavior, 2015, 149:262-268. doi: 10.1016/j.physbeh.2015.06.013.

Samuelson L., Scherer R., VanSaun M., Fan, K-H., Dozier, E., Carter, K., Shyr, Y., Aschner, M. Stanwood, G., Bornhop, D., Matrisian, L. & McIntyre, O. New tools for the preclinical quantitative assessment of peripheral neurotoxicity and prodrug delivery, Neurotoxicology. 2015 Feb 27;47:88-98. doi: 10.1016/j.neuro.2015.02.005.

Frederick, A.L., Yano, H., Triflieff, P., Vishwasrao, H.D., Biezonski, D., Mészáros, J., Sibley, D.R., Kellendonk, C., Sontag, K.C., Graham, D.L., Colbran, R.J., Stanwood, G.D. & Javitch, J. Evidence against dopamine D1/D2 receptor heteromers, Molecular Psychiatry, 2015, Jan 6. doi: 10.1038/mp.2014.166. [Epub ahead of print]. (Stanwood and Javitch are co-senior authors).

Palubinsky, A.M., Stankowski, J.N., Kale, A.C., Codreanu, S.G., Singer, R.J., Liebler, D.C., Stanwood, G.D. & McLaughlin, B.M. CHIP is an Essential Determinant of Neuronal Mitochondrial Stress Signaling. Antioxid Redox Signal. 2015 Jan 20. [Epub ahead of print].

Graham, D.L., Durai, H.H., Garden, J.D., Cohen, E., Echevarria, F.D. & Stanwood, G.D. Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex, 2014, ACS Chemical Neuroscience, Nov 24. [Epub ahead of print].

Mergy, M.A., Gowrishankar, R., Gresch, P.J., Gantz, S.C., Williams, J.T., Davis, G.L., Wheeler, C.A., Stanwood, G.D., Hahn, M.K. & Blakely, R.D. The rare dopamine transporter variant Val559 disrupts dopamine neuronal function, changes behavior and alters in vivo responses to psychostimulants, PNAS, 2014, Nov 4;111(44):E4779-88. doi: 10.1073/pnas.1417294111.

McClure, R., Yanagisawa, D., Stec, D., Abdollahian, D., Koktysh, D., Xhillari, D., Jaeger, R., Stanwood, G., Chekmenev E., Tooyama I., Gore J.C. & Pham, W. Inhalable curcumin: offering the potential for translation to imaging and treatment of Alzheimer's disease, Journal of Alzheimer’s Disease. 2014 Sep 16. [Epub ahead of print].

Coke-Murphy, C., Buendia, M.A., Saborido, T.P. & Stanwood, G.D. Simple shelter-style environmental enrichment alters behavior in mice, Translational Neuroscience, 2014, 5: 185-96.

Kocalis, H.E., Hagan, S.L., George, L., Turney, M.K., Siuta, M.A., Laryea, G.N., Morris, L.C., Muglia, L.J., Printz, R.L., Stanwood, G.D. & Niswender, K.D. Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasis. Molecular Metabolism, 2014, 3:394-407.

Holmstrand, E.C., Lund, D., Cheerian, A.K., Wright, J., Martin, R.F., Ennis, E.A., Stanwood, G.D., Sarter, M. & Blakely, R.D. Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance, Neurochemistry International, 2013, 73:217-28, PMID:24274995.

Mergy M.A., Gowrishankar R., Davis G.L., Jessen T.N., Wright J., Stanwood G.D., Hahn M.K. & Blakely R.D. Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: On the path to an animal model of attention-deficit hyperactivity disorder. Neurochemistry International, 2013, 73:56-70, PMID:24332984.

Cummins, E.D., Griffin, S.B., Burgess, K.C., Peterson, D.J., Watson, B.D., Buendia, M.A., Stanwood, G.D. & Brown, R.W. Methylphenidate place conditioning in adolescent rats: an analysis of sex differences and the dopamine transporter. Behavioural Brain Research 2013, 257:215-23, PMID:24084582.

Graham, D.L, Erreger K., Galli A. & Stanwood, G.D. GLP-1 analog attenuates cocaine reward, Molecular Psychiatry, 2013 Sep;18(9):961-2. doi: 10.1038/mp.2012.141. Epub 2012 Oct 23. PMID: 23089631.

Kocalis H.E., Turney M.K., Printz R.L., Laryea G.N., Muglia L.J., Davies S.S., Stanwood G.D., McGuinness O.P. & Niswender K.D. Neuron-Specific Deletion of Peroxisome Proliferator-Activated Receptor Delta (PPARδ) in Mice Leads to Increased Susceptibility to Diet-Induced Obesity. PLoS One. 2012, 7(8):e42981, Epub 2012 Aug 20, PMID: 22916190.

Killinger, C.E., Robinson, S. & Stanwood, G.D. Subtle biobehavioral effects produced by paternal cocaine exposure, Synapse, 2012, 66:902-8, PMID:22807092.

Frederick, A.L., Saborido, T.P. & Stanwood, G.D. Neurobehavioral phenotyping of G?q knockout mice reveals impairments in motor functions and spatial working memory without changes in anxiety or behavioral despair, Frontiers in Behavioral Neuroscience, 2012, 6:29. Epub 2012 Jun 19, PMID:22723772.

Jackson, C.R., Ruan, G.X., Aseem, F., Abey, J., Gamble, K., Stanwood, G., Palmiter, R., Iuvone, P.M. & McMahon, D. Retinal dopamine mediates multiple dimensions of light-adapted vision, Journal of Neuroscience, 2012, 32:9359-9368, PMID:22764243.

McLaughlin, B., Buendia, M.A., Saborido, T.P., Kleman, A.M. & Stanwood, G.D. C-terminus of heat shock cognate 70 Interacting Protein (CHIP) haploinsufficiency produces specific behavioral impairments, PLoS ONE, 7(5):e36340. Epub 2012 May 11, PMID: 22606257.

Carpenter, A.C., Saborido, T.P. & Stanwood, G.D. Development of behavioral responses in dopamine transporter deficient mice, Developmental Neuroscience, 2012, 34(2-3):250-7, PMID: 22572477.

Erreger K., Davis A.R., Poe A.M., Greig N.H., Stanwood G.D. & Galli A. Exendin-4 decreases amphetamine-induced locomotor activity. Physiology & Behavior, 2012, 106:574-8, PMID: 22465309.

Gustin, R.M., Shonesy, B.C., Robinson, S.L., Rentz, T.J., Baucum, A.J., Winder, D.G., Stanwood, G.D. & Colbran, R.J. Loss of Thr286 phosphorylation disrupts synaptic CaMKII? targeting, NMDAR activity and behavior in pre-adolescent mice. Molecular and Cellular Neuroscience, 47: 286-92, 2011, PMID: 21627991.

Olsen, C.M., Childs, D.S., Stanwood, G.D. & Winder, D.G. Operant Sensation Seeking Requires Metabotropic Glutamate Receptor 5 (mGluR5), PLoS ONE, 5: e15085, 2010, PMID: 21152045.

Swant, J., Chirwa, S., Stanwood, G. & Khoshbouei, H. Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus, PLoS ONE, 5: e11382, 2010, PMID: 20614033.

Siuta, M., Robertson, S., Kocalis, H., Saunders, C., Gresch, P., Khatri, V., Shiota, C., Kennedy, J.P., Lindsley, C., Daws, L., Polley, D., Veenstra-Vanderweele, J., Stanwood, G.D., Magnuson, M., Niswender, K. & Galli, A. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal Rictor null mice, PLoS Biology, 8:e1000393, 2010, PMID: 20543991.

Thompson, B.L., Stanwood, G.D. & Levitt, P. Specificity of prenatal cocaine exposure effects on cortical interneurons is independent from dopamine D1 receptor co-localization, Journal of Chemical Neuroanatomy, 39: 228-34, 2010, PMID: 20080176.

Kern, C, Stanwood, G.D. & Smith, D.R. Pre-weaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels, Synapse, 64: 363-78, 2010, PMID: 20029834.

Wang, H-D., Stanwood, G.D., Grandy, D.K. & Deutch, A.Y. Dystrophic dendrites in prefrontal cortical pyramidal cells of dopamine D1 and D2 but not D4 receptor knockout mice, Brain Research, 1300, 58-64, 2009, PMID: 19747903.

Neely, M.D., Stanwood, G.D. & Deutch, A.Y. Combination of DiOlistic labeling with retrograde tract tracing and immunohistochemistry, Journal of Neuroscience Methods, 184: 332-6, 2009, PMID: 19712695.

Stanwood, G.D., Leitch, D.B., Savchenko V., Wu, J., Fitsanakis, V.A., Anderson, D.J., Stankowski, J.N., Aschner, M. & McLaughlin, B. Chronic manganese exposure in mice is neurotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia, 110: 378-89, Journal of Neurochemistry, 2009, PMID: 19457100.

Cook, M.M., Brown, M.N., Mishra, P., Stanwood, G.D. & Mathews, G.C. Glutamate spillover enhances GABA synthesis and release from axodendritic synapses in rat hippocampus, Hippocampus, 20: 134-44, 2009, PMID: 19330818.

Jacobs, M., Emeson, R.B. & Stanwood, G.D. ADAR1 and ADAR2 expression during neurodevelopment, Developmental Neuroscience, 31: 223-37, 2009, PMID: 19325227.

Overton, D.A., Stanwood, G.D., Patel, B.N., Pragada, S.R. & Gordon, M.K. Measurement of the lowest dosage of phenobarbital that can produce drug discrimination in rats, Psychopharmacology, 203: 213-8, 2008, PMID: 19082292.

Couppis, M.H., Kennedy, C.H. & Stanwood, G.D. Alterations in the mesocorticolimbic dopamine system in mouse strains that differ in aggressive behavior, Synapse, 62: 714-725, 2008, PMID: 18651644.

Maple, A.M., Perna, M.K., Parlaman, J.P., Stanwood, G.D. & Brown, RW. Neonatal quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens, and frontal cortex, European Journal of Neuroscience, 26: 2532-38, 2007, PMID: 17970732.

Parlaman, J.P., Thompson, B.L., Levitt, P. & Stanwood, G.D. Pharmacokinetic profile of cocaine following intravenous administration in the female rabbit, European Journal of Pharmacology, 563: 124-29, 2007, PMID: 17383635.

Stanwood, G.D. & Levitt, P. Waved-1 mutant mice are hypersensitive to the locomotor actions of cocaine, Synapse, 61: 259-62, 2007, PMID: 17230552.

Stanwood, G.D. & Levitt, P. Prenatal exposure to cocaine produces unique developmental and long-term adaptive changes in dopamine D1 receptor activity and subcellular distribution, Journal of Neuroscience, 27: 152-7, 2007, PMID: 17202482.

Stanwood, G.D., Parlaman, J.P. & Levitt, P. Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G-protein signaling (Rgs) transcripts, European Journal of Neuroscience, 24:806-818, 2006, PMID:16930410.

Desplats, P.A., Kass, K.E., Gilmartin, T., Stanwood, G.D., Woodward, E.L., Head, S.R., Sutcliffe, J.G. & Thomas, E.A. Selective deficits in the expression of striatal-enriched mRNAs in Huntington’s disease, Journal of Neurochemistry, 96: 743-57, 2006, PMID: 16405510.

Thompson, B.L., Levitt, P. & Stanwood, G.D. Prenatal cocaine specifically alters spontaneous alternation behavior, Behavioural Brain Research, 164: 107-16, 2005, PMID: 16054247.

Stanwood, G.D., Parlaman, J.P. & Levitt, P. Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D1 receptor mutant mice, Journal of Comparative Neurology, 487: 270-82, 2005, PMID: 15892099.

Stanwood, G.D. & Levitt, P. Repeated intravenous cocaine exposure produces long-lasting behavioral sensitization in pregnant adults, but behavioral tolerance in their offspring, Neuroscience, 122: 579-583, 2003, PMID: 14622900.

Powell, E.M., Campbell, D.B., Stanwood, G.D., Davis, C., Noebels, J.L. & Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction, Journal of Neuroscience, 23: 622-31, 2003, PMID: 12533622.

Rittenhouse, P.A., López-Rubalcava, C., Stanwood, G.D. & Lucki, I. Amplified behavioral and endocrine responses to forced swim stress in the Wistar–Kyoto rat, Psychoneuroendocrinology, 27: 303-318, 2002, PMID: 11818168.

Stanwood, G.D., Washington, R.A., Shumsky, J.S. & Levitt, P. Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex, Neuroscience, 106: 5-14, 2001, PMID: 11564412.

Stanwood, G.D., Washington, R.A. & Levitt, P. Identification of a sensitive period of prenatal cocaine exposure that alters the development of the anterior cingulate cortex, Cerebral Cortex, 11: 430-440, 2001, PMID: 11313295.

Mirnics, K., Middleton, F.A., Stanwood, G.D., Lewis, D.A. & Levitt, P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia, Molecular Psychiatry, 6: 293-301, 2001, PMID: 11326297.

Jones, L.B., Stanwood, G.D., Reinoso, B.S., Washington, R.A., Wang, H-Y, Friedman E. & Levitt, P. In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons, Journal of Neuroscience, 20, 4606-4614, 2000, PMID: 10844030. (Stanwood and Jones were co-first authors).

Pearl, S.M., Antion, M.D., Stanwood, G.D., Jaumotte, J.D., Kapatos, G. & Zigmond, M.J. Effects of NADH on dopamine release in rat striatum, Synapse, 36: 95-101, 2000, PMID: 10767056.

Stanwood, G.D., Artymyshyn, R.P., Kung, M.-P., Kung, H.F., Lucki, I. & McGonigle, P. Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [125I]-7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and non-dopaminergic cell bodies and terminals, Journal of Pharmacology and Experimental Therapeutics, 295: 1223-1231, 2000, PMID: 11082459.

Stanwood, G.D., Lucki, I. & McGonigle, P. Differential regulation of dopamine D2 and D3 receptors by chronic drug administration, Journal of Pharmacology and Experimental Therapeutics, 295: 1232-1240, 2000, PMID: 11082460.

Stanwood, G.D., McElligot, S., Lu, L. & McGonigle, P. Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat, Neuroscience Letters, 223: 13-16, 1997, PMID: 9058411.

Reviews / Book Chapters / Commentaries

Delva, N.C. & Stanwood, G.D. Dysregulation of brain dopamine systems in major depressive disorder. Experimental Biology and Medicine, 2021Exp Biol Med (Maywood). 2021 Feb 16:1535370221991830. doi: 10.1177/1535370221991830. PMID: 33593109

Goldfarb, S.S, Stanwood, G.D., Flynn, H.A., & Graham, D.L. Developmental opioid exposures: neurobiological underpinnings, behavioral impacts and policy implications, Experimental Biology and Medicine, 2019 Oct 20:1535370219883601. doi: 10.1177/1535370219883601. 

Beerse, M.E., Van Lith, T., Pickett, S.M., & Stanwood, G.D. Is There a Biofeedback Response to Art Therapy? Biobehavioral utility of mindfulness-based art therapy: neurobiological underpinnings and mental health impacts, Experimental Biology and Medicine, 2020 Jan;245(2):122-130. doi: 10.1177/1535370219883634.

Stanwood, G.D. Dopamine and Stress. In George Fink (Ed.), Handbook of Stress, 3rd edition. Elsevier, 2019, pp. 105-114.

Graham, D.L., Meyer, J.S. & Stanwood, G.D. Behavioral phenotyping in developmental neurotoxicology – simple approaches using unconditioned behaviors in rodents, Handbook of Developmental Neurotoxicology, 2nd edition, edited by W. Slikker, M. Paule & C. Wang, Elsevier, 2018, pp. 287-308.

Martin, M.M., Graham, D.L., McCarthy, D.M., Bhide, P.G., & Stanwood, G.D. Cocaine-induced neurodevelopmental deficits and underlying mechanisms, Birth Defects Res C Embryo Today, 2016 Jun;108(2):147-73. doi: 10.1002/bdrc.21132.

Ross, E.J., Graham, D.L., Money, K.M. & Stanwood, G.D. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn, Neuropsychopharmacology Reviews, 2014, Jun 18. doi: 10.1038/npp.2014.147. 

Money, K.M. & Stanwood, G.D. Developmental origins of brain disorders: roles for dopamine, Frontiers in Cellular Neuroscience, 2013 Dec 19; 7:260. PMID:24391541.

Reddy, I.A., Stanwood, G.D. & Galli A. Moving beyond energy homeostasis: New roles for glucagon-like peptide-1 in food and drug reward, Neurochemistry International, 2013 Oct 16. pii: S0197-0186(13)00259-3. doi: 10.1016/j.neuint.2013.10.003., PMID:24140429.

Thompson, B.L., Levitt, P. & Stanwood, G.D. The effects of prenatal exposure to drugs on brain development and function: implications for policy and education, Nature Neuroscience Reviews, 10:303-12, 2009. PMID: 19277053

Frederick, A.L. & Stanwood, G.D. Drugs, biogenic amine targets and the developing brain, Developmental Neuroscience, 31: 7-22, 2009. PMID: 19372683

Thompson, B.L. & Stanwood, G.D. Pleiotropic effects of neurotransmission during development: modulators of modularity, Journal of Autism and Developmental Disabilities, 39: 260-268, 2009. PMID: 18648918

Stanwood, G.D. & Levitt, P. The effects of monoamines on the developing nervous system, Handbook of Developmental Cognitive Neuroscience 2nd ed., edited by Nelson, C.A. & Luciana, M., MIT Press, 83-94, 2008.

Stanwood, G.D. Protein-protein interactions and dopamine D2 receptor signaling: a calcium connection, Molecular Pharmacology, 74, 317-319, 2008. PMID: 18511653Stanwood, G.D. Dopamine, Central, Encyclopedia of Stress 2nd ed., Fink, G. ed, Academic Press, 852-859, 2007.

Stanwood, G.D. & Levitt, P. Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development, Current Opinion in Pharmacology, 4, 65-71, 2004. PMID: 15018841

Stanwood, G.D. & Levitt, P. The effects of cocaine on the developing nervous system, Handbook of Developmental Cognitive Neuroscience, edited by Nelson, C.A. & Luciana, M., MIT Press, 519-536, 2001.

Stanwood, G.D. & Levitt, P. “Prenatal cocaine exposure as a risk factor for later developmental outcomes”, JAMA, 286, 45 (discussion 46-47), 2001. PMID: 11434821

Stanwood, G.D. & Zigmond, M.J. “Dopamine, Central”, Encyclopedia of Stress, Fink, G. ed, Academic Press, 739-746, 2000, PMID: 10767056.